A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: consequently (22), thus (80), hence (63)

Peripheral plasma exchange - patient information

Description
This factsheet is a guide to having plasma exchange treatment.
Url
/Media/UHS-website-2019/Patientinformation/Blooddisorders/Peripheral-plasma-exchange-1587-PIL.pdf

Specialty Research Lead JD May 2022

Description
Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size of
Url
/Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-May-2022.pdf

Specialty Research Lead JD May 2022.docx

Description
Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size of
Url
/Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-May-2022.docx.pdf

Papers Council of Governors - 27 April 2022

Description
Date Time Location Chair Agenda Council of Governors 27/04/2022 14:00 - 16:00 Microsoft Teams Jane Bailey 1 Chair
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Council-of-Governors-27-April-2022.pdf

Specialty Research Lead JD March 2022

Description
Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size of
Url
/Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-March-2022.pdf

Rituximab (8 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as first
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lymphoma as maintenance monotherapy for relapsed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf

Bexarotene

Description
Chemotherapy Protocol Cutaneous T-cell Lymphoma BEXAROTENE Regimen • Cutaneous T-cell Lymphoma - Bexarotene Indication • Bexarotene is indi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bexarotene.pdf

Regorafenib

Description
Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

Ponatinib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Ponatinib All licensed indications are not funded therefore an application for funding is required before prescribing
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Ponatinib.pdf
211 to 220 of 344
Previous … 20 21 22 23 24 … Next